Stochastic dynamics and the evolution of mutations in stem cells

被引:16
作者
Dingli, David [1 ,2 ]
Pacheco, Jorge M. [3 ,4 ]
机构
[1] Mayo Clin, Coll Med, Div Hematol, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Dept Mol Med, Rochester, MN 55905 USA
[3] Univ Minho, Dept Matemat & Aplicacoes, P-4710057 Braga, Portugal
[4] Ctr Matemat & Aplicacoes Fundamentais, ATP Grp, P-1649003 Lisbon, Portugal
来源
BMC BIOLOGY | 2011年 / 9卷
关键词
PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; NATURAL-HISTORY; CYCLIC NEUTROPENIA; NORMAL INDIVIDUALS; SOMATIC MUTATIONS; CD34(+) CELLS; CANCER; HEMATOPOIESIS;
D O I
10.1186/1741-7007-9-41
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Stem cells are the target of mutations that can lead to life threatening diseases. However, stem cell populations tend to be small and therefore clonal expansion of mutant cells is highly sensitive to stochastic fluctuations. The evolutionary dynamics of mutations in these cells is discussed, taking into consideration the impact of such mutations on the reproductive fitness of cells. We show how stochastic effects can explain clinical observations, including extinction of acquired clonal stem cell disorders.
引用
收藏
页数:7
相关论文
共 51 条
  • [1] [Anonymous], 2001, Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues
  • [2] The mutation rate in PIG-A is normal in patients with paroxysmal nocturnal hemoglobinuria (PNH)
    Araten, David J.
    Luzzatto, Lucio
    [J]. BLOOD, 2006, 108 (02) : 734 - 736
  • [3] Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): no evidence for intrinsic growth advantage of PNH clones
    Araten, DJ
    Bessler, M
    McKenzie, S
    Castro-Malaspina, H
    Childs, BH
    Boulad, F
    Karadimitris, A
    Notaro, R
    Luzzatto, L
    [J]. LEUKEMIA, 2002, 16 (11) : 2243 - 2248
  • [4] Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals
    Araten, DJ
    Nafa, K
    Pakdeesuwan, K
    Luzzatto, L
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (09) : 5209 - 5214
  • [5] Clinical and molecular aspects of 23 patients affected by paroxysmal nocturnal hemoglobinuria
    Boschetti, C
    Fermo, E
    Bianchi, P
    Vercellati, C
    Barraco, F
    Zanella, A
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2004, 77 (01) : 36 - 44
  • [6] The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: Biologic significance and implications for the assessment of minimal residual disease
    Bose, S
    Deininger, M
    Gora-Tybor, J
    Goldman, JM
    Melo, JV
    [J]. BLOOD, 1998, 92 (09) : 3362 - 3367
  • [7] Accumulation of driver and passenger mutations during tumor progression
    Bozic, Ivana
    Antal, Tibor
    Ohtsuki, Hisashi
    Carter, Hannah
    Kim, Dewey
    Chen, Sining
    Karchin, Rachel
    Kinzler, Kenneth W.
    Bogelstein, Bert
    Nowak, Martin A.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (43) : 18545 - 18550
  • [8] BROUN ER, 1990, CANCER GENET CYTOGEN, V46, P125
  • [9] USE OF AN X-LINKED HUMAN NEUTROPHIL MARKER TO ESTIMATE TIMING OF LYONIZATION AND SIZE OF THE DIVIDING STEM-CELL POOL
    BUESCHER, ES
    ALLING, DW
    GALLIN, JI
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (04) : 1581 - 1584
  • [10] MUTATION SELECTION AND NATURAL-HISTORY OF CANCER
    CAIRNS, J
    [J]. NATURE, 1975, 255 (5505) : 197 - 200